NICE announce criteria for access to Daklinza, Harvoni, Viekirax and Exviera

BY IN Medication, Research NO COMMENTS YET , , , ,

The National Institute of Clinical Excellence (NICE) have announced which of the new treatments will be made available by the NHS to people living with hepatitis C. The NICE decisions will widen access to a range of new all-oral, direct acting antiviral treatments beyond those patients with decompensated cirrhosis who were treated from 2014 under

CONTINUE READING …

New Booklet: Pocket-Size ART Guide

BY IN Medication NO COMMENTS YET ,

The people at HIV i-Base, have just published an excellent pocket version of their ‘Introduction to ART’ leaflet. You can download it here. The Pocket ART guide is an informative but easy-to-read way to access the most accurate information about antiretroviral treatment. Lenny, an HIV positive person involved with the booklet, says in its pages:“I know I was

CONTINUE READING …

NHS England agrees funding for life-saving hepatitis C drug

BY IN Medication NO COMMENTS YET ,

NHS England has approved an £18.7 million investment in a new drug for the treatment of hepatitis C. Around 500 patients with acute liver failure, and/or awaiting liver transplantation, are expected to benefit from the decision to fund Sofosbuvir. The hepatitis C virus causes inflammation of the liver, affecting its ability to function. Whilst many

CONTINUE READING …